Cancer Drug Prices May Fall As Margins Are Capped At 30%
· Business · Indian Express, India Today
The Indian government is moving to cap trade margins on high-cost cancer medicines at 30% over the cost to distributors in New Delhi. The policy targets expensive and frequently used cancer drugs, including patented medicines, and could reduce maximum retail prices by up to 70%. A committee headed by the Director General of Health Services is currently drawing up the list of eligible medicines. The measure is expected to take effect within 10 days. Officials stated that cheaper drugs are excluded from the cap to prevent companies from discontinuing their marketing due to inadequate distribution margins.
Why it matters
Cancer patients across India face steep treatment costs, and this margin cap directly targets expensive therapies to lower out-of-pocket expenses for families.
Read the original report — Indian Express
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.